Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 2
2017 5
2018 3
2019 1
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.
Madelain V, Mentré F, Baize S, Anglaret X, Laouénan C, Oestereich L, Nguyen THT, Malvy D, Piorkowski G, Graw F, Günther S, Raoul H, de Lamballerie X, Guedj J. Madelain V, et al. CPT Pharmacometrics Syst Pharmacol. 2020 May;9(5):258-271. doi: 10.1002/psp4.12510. Epub 2020 Apr 28. CPT Pharmacometrics Syst Pharmacol. 2020. PMID: 32198838 Free PMC article. Review.
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.
Nguyen TH, Guedj J, Anglaret X, Laouénan C, Madelain V, Taburet AM, Baize S, Sissoko D, Pastorino B, Rodallec A, Piorkowski G, Carazo S, Conde MN, Gala JL, Bore JA, Carbonnelle C, Jacquot F, Raoul H, Malvy D, de Lamballerie X, Mentré F; JIKI study group. Nguyen TH, et al. Among authors: madelain v. PLoS Negl Trop Dis. 2017 Feb 23;11(2):e0005389. doi: 10.1371/journal.pntd.0005389. eCollection 2017 Feb. PLoS Negl Trop Dis. 2017. PMID: 28231247 Free PMC article. Clinical Trial.
CT and clinical prognostic factors in Bell's palsy: A study of 56 cases.
Hervochon R, Madelain V, Seiller I, Lahlou G, Nguyen Y, Tankéré F. Hervochon R, et al. Among authors: madelain v. Clin Otolaryngol. 2019 Sep;44(5):861-864. doi: 10.1111/coa.13392. Epub 2019 Jul 7. Clin Otolaryngol. 2019. PMID: 31220409 No abstract available.
Optimal Maturation of the SIV-Specific CD8+ T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC Study.
Passaes C, Millet A, Madelain V, Monceaux V, David A, Versmisse P, Sylla N, Gostick E, Llewellyn-Lacey S, Price DA, Blancher A, Dereuddre-Bosquet N, Desjardins D, Pancino G, Le Grand R, Lambotte O, Müller-Trutwin M, Rouzioux C, Guedj J, Avettand-Fenoel V, Vaslin B, Sáez-Cirión A. Passaes C, et al. Among authors: madelain v. Cell Rep. 2020 Sep 22;32(12):108174. doi: 10.1016/j.celrep.2020.108174. Cell Rep. 2020. PMID: 32966788 Free article.
Erratum for Madelain et al., "Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses".
Madelain V, Guedj J, Mentré F, Nguyen THT, Jacquot F, Oestereich L, Kadota T, Yamada K, Taburet AM, de Lamballerie X, Raoul H. Madelain V, et al. Antimicrob Agents Chemother. 2017 Dec 21;62(1):e02093-17. doi: 10.1128/AAC.02093-17. Print 2018 Jan. Antimicrob Agents Chemother. 2017. PMID: 29269432 Free PMC article. No abstract available.
Ebola virus dynamics in mice treated with favipiravir.
Madelain V, Oestereich L, Graw F, Nguyen TH, de Lamballerie X, Mentré F, Günther S, Guedj J. Madelain V, et al. Antiviral Res. 2015 Nov;123:70-7. doi: 10.1016/j.antiviral.2015.08.015. Epub 2015 Sep 2. Antiviral Res. 2015. PMID: 26343011 Free article.
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page